Science

Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC

Federica Pecci/X

Apr 26, 2025, 16:35

Federica Pecci: Factors linked to prolonged disease control after stopping ICIs for irAEs in advanced NSCLC

Federica Pecci, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a paper she co-authored with colleagues published in Clinical Cancer Research,:

“Just published in Clinical Cancer Research, our work studying factors associated with prolonged disease control and survival after discontinuation of immune checkpoint inhibitors for irAEs in patients with advanced NSCLC.”

“Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non–Small Cell Lung Cancer”

Authors: Federica Pecci, Rohit Thummalapalli, Stephanie Alden, Biagio Ricciuti, Joao Alessi, Mizuki Nishino, Bruce Johnson, Matthew Hellmann, Adam Schoenfeld, Mark Awad et al.

More posts featuring Federica Pecci.

Adam Schoenfeld Biagio Ricciuti Bruce Johnson cancer Clinical Cancer Research Federica Pecci João Alessi Mark Awad Matthew Hellmann Mizuki Nishino non small cell lung cancer NSCLC OncoDaily Oncology Rohit Thummalapalli Stephanie Alden

Douglas Flora: Fighting Cancer with Heart

Eric Small: Deeply Honored to Step Into the Role of 2025-26 ASCO President

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart

20 Posts Not to Miss from ASCO 2025